Immune infiltration analysis based on pyroptosis-related gene in metabolic dysfunction-associated fatty liver disease

被引:0
|
作者
Lian, Xin [1 ]
Tang, Xulei [1 ]
机构
[1] Lanzhou Univ, Clin Med Coll 1, Lanzhou 730000, Gansu, Peoples R China
关键词
Metabolic dysfunction-associated fatty liver; disease; Pyroptosis-related gene; Immune infiltration; Bioinformatics; NONALCOHOLIC STEATOHEPATITIS; EXPRESSION; PROTEIN; PATHOPHYSIOLOGY; INFLAMMASOMES; HEPATOCYTES; PROGRESSION; ACTIVATION; MECHANISMS; SIGNATURES;
D O I
10.1016/j.heliyon.2024.e34348
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a prevalent chronic disease that can involve pyroptosis. The primary objective of this study was to conduct a thorough and comprehensive analysis the pyroptosis-related genes in MAFLD. Methods: We identified pyroptosis-related differentially expressed genes (PRDEGs) in both healthy individuals and MAFLD patients. Using various bioinformatic approaches, we conducted an immune infiltration analysis from multiple perspectives. Results: A total of 20 pyroptosis-related LASSO genes were obtained, and 10 hub genes were used to do immune infiltration analysis. The hub genes were utilized in the construction of interaction networks between mRNA-miRNA and mRNA-TF. Immune characteristics analysis revealed multiple immune cell types significantly related to PRDEG expression, particularly genes HSP90AA1, TSLP, CDK9, and BRD4. Conclusion: Pyroptosis-related immune infiltration might be a mechanism of MAFLD progression and offers a research direction for potential treatment techniques.
引用
收藏
页数:27
相关论文
共 50 条
  • [31] Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink
    Fernandez, Cornelius J.
    Alkhalifah, Mohammed
    Afsar, Hafsa
    Pappachan, Joseph M.
    PATHOGENS, 2024, 13 (01):
  • [32] Non-invasive assessment of metabolic dysfunction-associated fatty liver disease
    Chandra Kumar, C. Vikneshwaran
    Skantha, Ruben
    Chan, Wah-Kheong
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022, 13
  • [33] Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers
    Liu, Zhenqiu
    Lin, Chunqing
    Suo, Chen
    Zhao, Renjia
    Jin, Li
    Zhang, Tiejun
    Chen, Xingdong
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 127
  • [34] A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
    Eslam, Mohammed
    Newsome, Philip N.
    Sarin, Shiv K.
    Anstee, Quentin M.
    Targher, Giovanni
    Romero-Gomez, Manuel
    Zelber-Sagi, Shira
    Wong, Vincent Wai-Sun
    Dufour, Jean-Francois
    Schattenberg, Joern M.
    Kawaguchi, Takumi
    Arrese, Marco
    Valenti, Luca
    Shiha, Gamal
    Tiribelli, Claudio
    Yki-Jarvinen, Hannele
    Fan, Jian-Gao
    Gronbaek, Henning
    Yilmaz, Yusuf
    Cortez-Pinto, Helena
    Oliveira, Claudia P.
    Bedossa, Pierre
    Adams, Leon A.
    Zheng, Ming-Hua
    Fouad, Yasser
    Chan, Wah-Kheong
    Mendez-Sanchez, Nahum
    Ahn, Sang Hoon
    Castera, Laurent
    Bugianesi, Elisabetta
    Ratziu, Vlad
    George, Jacob
    JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 202 - 209
  • [35] Association between multiple metals exposure and metabolic dysfunction-associated fatty liver disease among Chinese adults
    Liu, Qing
    Bi, Jianing
    Fan, Gaojie
    Wu, Mingyang
    Qin, Xiya
    Fang, Qing
    Mei, Surong
    Wan, Zhengce
    Lv, Yongman
    Song, Lulu
    Wang, Youjie
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2024, 86
  • [36] The multiple mechanisms and therapeutic significance of rutin in metabolic dysfunction-associated fatty liver disease (MAFLD)
    Wang, Qianzhuo
    Zhang, Yingjuan
    Lu, Ruiling
    Zhao, Qingwen
    Gao, Yue
    FITOTERAPIA, 2024, 178
  • [37] Metabolic dysfunction-associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity
    Tao, Jie
    Li, Hong
    Wang, Honggang
    Tan, Juan
    Yang, Xiaozhong
    OSTEOPOROSIS INTERNATIONAL, 2024, 35 (12) : 2087 - 2098
  • [38] Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma
    Liu, Ze-Kun
    Wu, Ke-Fei
    Zhang, Ren-Yu
    Kong, Ling-Min
    Shang, Run-Ze
    Lv, Jian-Jun
    Li, Can
    Lu, Meng
    Yong, Yu-Le
    Zhang, Cong
    Zheng, Nai-Shan
    Li, Yan-Hong
    Chen, Zhi-Nan
    Bian, Huijie
    Wei, Ding
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [39] Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease
    Kountouras, Jannis
    Kazakos, Evangelos
    Polyzos, Stergios A.
    Papaefthymiou, Apostolis
    Zavos, Christos
    Tzitiridou-Chatzopoulou, Maria
    Chatzopoulos, Dimitrios
    Vardaka, Elisabeth
    Gatopoulou, Anthia
    Kyrailidi, Foteini
    Mouratidou, Maria C.
    Doulberis, Michael
    CLINICAL IMMUNOLOGY, 2023, 256
  • [40] Uncovering Actions of Type 3 Deiodinase in the Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
    Marschner, Rafael Aguiar
    Roginski, Ana Cristina
    Ribeiro, Rafael Teixeira
    Longo, Larisse
    Alvares-da-Silva, Mario Reis
    Wajner, Simone Magagnin
    CELLS, 2023, 12 (07)